Previous close | 7.84 |
Open | 7.86 |
Bid | 7.50 x 10000 |
Ask | 7.60 x 10000 |
Day's range | 7.40 - 7.94 |
52-week range | 7.40 - 25.75 |
Volume | |
Avg. volume | 736 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LATHAM, N.Y., July 12, 2023--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced financial results for the fourth quarter and fiscal year 2023, which ended May 31, 2023.